학술논문
Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer.
Document Type
Article
Author
Novoplansky, Ofra; Shnerb, Avital B.; Marripati, Divyasree; Jagadeeshan, Sankar; Abu Shareb, Raghda; Conde‐López, Cristina; Zorea, Jonathan; Prasad, Manu; Ben Lulu, Talal; Yegodayev, Ksenia M.; Benafsha, Chen; Li, Yushi; Kong, Dexin; Kuo, Fengshen; Morris, Luc G. T.; Kurth, Ina; Hess, Jochen; Elkabets, Moshe
Source
Molecular Oncology; Dec2023, Vol. 17 Issue 12, p2618-2636, 19p
Subject
Language
ISSN
15747891